PIONEER COVID-19 trial wins funding injection from LifeArc
The funds will enable researchers to investigate the science around the trial, including why coronavirus affects some people more than others
Read More
Tag: Chelsea and Westminster
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
